chr2-178740998-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001267550.2(TTN):ā€‹c.12235A>Gā€‹(p.Ile4079Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0199 in 1,613,934 control chromosomes in the GnomAD database, including 430 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.014 ( 36 hom., cov: 32)
Exomes š‘“: 0.020 ( 394 hom. )

Consequence

TTN
NM_001267550.2 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 0.332
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003384471).
BP6
Variant 2-178740998-T-C is Benign according to our data. Variant chr2-178740998-T-C is described in ClinVar as [Benign]. Clinvar id is 47823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178740998-T-C is described in Lovd as [Benign]. Variant chr2-178740998-T-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0144 (2198/152316) while in subpopulation SAS AF= 0.0427 (206/4826). AF 95% confidence interval is 0.0379. There are 36 homozygotes in gnomad4. There are 1074 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 36 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TTNNM_001267550.2 linkc.12235A>G p.Ile4079Val missense_variant 48/363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.12235A>G p.Ile4079Val missense_variant 48/3635 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2201
AN:
152198
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00437
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0251
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0429
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0192
Gnomad OTH
AF:
0.0244
GnomAD3 exomes
AF:
0.0176
AC:
4374
AN:
248276
Hom.:
66
AF XY:
0.0194
AC XY:
2618
AN XY:
134650
show subpopulations
Gnomad AFR exome
AF:
0.00368
Gnomad AMR exome
AF:
0.0168
Gnomad ASJ exome
AF:
0.0140
Gnomad EAS exome
AF:
0.000167
Gnomad SAS exome
AF:
0.0411
Gnomad FIN exome
AF:
0.00172
Gnomad NFE exome
AF:
0.0194
Gnomad OTH exome
AF:
0.0212
GnomAD4 exome
AF:
0.0204
AC:
29879
AN:
1461618
Hom.:
394
Cov.:
32
AF XY:
0.0211
AC XY:
15314
AN XY:
727092
show subpopulations
Gnomad4 AFR exome
AF:
0.00317
Gnomad4 AMR exome
AF:
0.0179
Gnomad4 ASJ exome
AF:
0.0150
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.0422
Gnomad4 FIN exome
AF:
0.00212
Gnomad4 NFE exome
AF:
0.0210
Gnomad4 OTH exome
AF:
0.0209
GnomAD4 genome
AF:
0.0144
AC:
2198
AN:
152316
Hom.:
36
Cov.:
32
AF XY:
0.0144
AC XY:
1074
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.00433
Gnomad4 AMR
AF:
0.0250
Gnomad4 ASJ
AF:
0.00923
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0427
Gnomad4 FIN
AF:
0.00123
Gnomad4 NFE
AF:
0.0192
Gnomad4 OTH
AF:
0.0236
Alfa
AF:
0.0188
Hom.:
44
Bravo
AF:
0.0147
TwinsUK
AF:
0.0232
AC:
86
ALSPAC
AF:
0.0205
AC:
79
ESP6500AA
AF:
0.00538
AC:
20
ESP6500EA
AF:
0.0185
AC:
152
ExAC
AF:
0.0179
AC:
2157
Asia WGS
AF:
0.0130
AC:
45
AN:
3478
EpiCase
AF:
0.0232
EpiControl
AF:
0.0254

ClinVar

Significance: Benign
Submissions summary: Benign:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 17, 2012Ile3841Val in exon 49 of TTN: This variant is not expected to have clinical sign ificance because it has been identified in 1.8% (122/6610) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs34070843). -
Benign, criteria provided, single submitterclinical testingGeneDxOct 07, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not provided Benign:5
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 13, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 24, 2019- -
Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 10, 2021- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Early-onset myopathy with fatal cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 10, 2021- -
Tibial muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 10, 2021- -
Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 10, 2021- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
4.6
DANN
Benign
0.50
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.58
T;T;.;T;T;T
MetaRNN
Benign
0.0034
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.22
N;.;.;N;N;.
REVEL
Benign
0.073
Sift
Benign
0.67
T;.;.;T;T;.
Vest4
0.025
MPC
0.070
ClinPred
0.00065
T
GERP RS
-1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34070843; hg19: chr2-179605725; API